Abstract:Shenqi compound formula has been widely utilized to improve aging -related diabetic nephropathy. Nevertheless, the underlying active ingredients and their molecular mechanisms of action remain doubtful. Thus, we aimed to identify the Shenqi compound formula mechanism involved in diabetic nephropathy treatment using system pharmacology. Candidate constituents and targets of Shenqi compound formula were obtained from traditional Chinese medicine systems pharmacology database. DisGeNET and GeneCards were utilized to build a diabetic nephropathy target database. A interactive network diagram of "drug -active ingredient -target" was fabricated employing Cytoscape. Employing Search Tool for Retrieval of Interacting Genes database, a protein -protein interaction network was established, protein -protein interaction relationships were analyzed, and visual analysis was implemented. Afterwards, gene ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis were implemented to identify the common targets. Finally, AutoDock Vina and PyMoL were utilized to confirm the molecular docking of key targets. Using electron microscopy, the morphological structure of MPC5 cells was observed. Western blotting was implemented to confirm the protein level in MPC5 cells. A total of 165 bioactive Shenqi formula compounds and 566 related target genes were obtained from traditional Chinese medicine systems pharmacology database. Furthermore, 521 diabetic nephropathyrelated target genes were obtained from GeneCard and DisGeNet databases. We observed that Shenqi compound formula and diabetic nephropathy share 130 common target genes, providing a molecular basis to treat diabetic nephropathy with Shenqi compound formula. Protein -protein interaction visualization analysis showed that protein kinase 1, albumin, and insulin were key target genes. The key components apigenin, glycine, and quercetin were obtained using degree values. Enrichment analysis showed that Shenqi compound formula interfered with diabetic nephropathy related signaling. Nephrotic syndrome type 2 and synaptopodin levels were markedly inferior to normal in the high glucose state, but increased after Shenqi compound formula treatment, as determined by Western blotting. Shenqi compound formula treats diabetic nephropathy using multi -component, multi -target, and multi -channel mechanisms. It was demonstrated that Shenqi compound formula has a beneficial effect on diabetes.

Syndrome Differentiation Through Drug Effects in Mapping the Two Regulatory Pathways of Gene Networks in Shen Deficiency Syndrome

[Comparison of Gene Expression Profiles Between Rats of Shen Deficiency Syndrome and Shen-yang Deficiency Syndrome Differentiated According to Therapeutic Efficacy of Drugs Used].

[Studies of gene networks and singal transduction of kidney deficiency syndrome by syndrome differentiation through drug effects]

[Establishment of a Quantitative Mathematical Model of Shen-deficiency Syndrome Based on Whole-Genome Transcriptional Profiles].

[Transition of Studying on Shen Deficiency Syndrome and Aging from Holistic Concept to Systematic Biologic Viewpoint].

Comparing the pharmacological effects of the prepared folium of Epimedium brevicornu Maxim. and Epimedium sagittatum Maxim. on kidney-Yang deficiency syndrome and liver injury complications

Exploration on Molecular Mechanism of Epimediun Flavonoids in Regulating Adrenocortical Regeneration in Rats with Inhibited Hypothalamic-Pituitary-Adrenal Axis Using Oligonucleotide Microarrays

[Activating Effect and Mechanism of Epimedium on Endogenous Stem Cells].

Serum metabolomics strategy for understanding pharmacological effects of ShenQi pill acting on kidney yang deficiency syndrome

Network Pharmacology-Based Investigation of the Molecular Mechanisms of the Chinese Herbal Formula Shenyi in the Treatment of Diabetic Nephropathy

The pharmacological effects and safety of the raw and prepared folium of Epimedium brevicornu Maxim. on improving kidney-yang deficiency syndrome and sexual dysfunction

Study on Shenbao Tablet in Treating Kidney-yang Deficiency Syndromebased on Metabolomics

Evaluation of the mechanism of Danggui-Shaoyao-San in regulating the metabolome of nephrotic syndrome based on urinary metabonomics and bioinformatics approaches

Validation of Protective Effect of Shenqi Compound on Aging-Related Diabetic Nephropathy: Evidence from Network Pharmacology and Experimental Exploration for MPC5 Cell Line

[Chinmedomics strategy to discover effective constituents and elucidate action mechanism of Nanshi capsule against kidney-yang deficiency syndrome]

[Study on the Regulative Rule of Reinforcing Shen Principle on Sexual Precocity and Senescence at the Molecular Level].

[Effect and Mechanism of Epimedium Flavanoids for Aging Retardation from Viewpoint of Transcriptomics and Metabonomics].

Integrating network pharmacology and experimental validation to decipher the mechanism of the Chinese herbal prescription modified Shen-Yan-Fang-Shuai formula in treating diabetic nephropathy

Molecular mechanism of Shengyang Yiwei Decoction in treating chronic kidney disease based on network pharmacology

Network Pharmacology to Uncover the Biological Basis of Spleen Qi Deficiency Syndrome and Herbal Treatment

The Antidepressant-Like Effects of Shen Yuan in a Chronic Unpredictable Mild Stress Rat Model